n(g),n(g')-dimethyl-l-arginine has been researched along with Essential Hypertension in 2 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Essential Hypertension: Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500
| Excerpt | Relevance | Reference |
|---|---|---|
| "Asymmetric dimethylarginine (ADMA) is a robust marker of endothelial dysfunction in patients with essential hypertension." | 7.88 | Asymmetric dimethylarginine levels are associated with augmentation index across naïve untreated patients with different hypertension phenotypes. ( Anyfanti, P; Dipla, K; Douma, S; Gavriilaki, E; Gkaliagkousi, E; Koletsos, N; Lazaridis, A; Nikolaidou, B; Triantafyllou, A; Vamvakis, A, 2018) |
| "This study was to assess the relationship between asymmetric dimethylarginine (ADMA) and carotid atherosclerosis in patients with essential hypertension." | 7.81 | Asymmetric dimethylarginine is associated with carotid atherosclerosis in patients with essential hypertension. ( Wang, X; Xia, W; Xu, L; Xu, W; Yao, Y, 2015) |
| "Asymmetric dimethylarginine (ADMA) is a robust marker of endothelial dysfunction in patients with essential hypertension." | 3.88 | Asymmetric dimethylarginine levels are associated with augmentation index across naïve untreated patients with different hypertension phenotypes. ( Anyfanti, P; Dipla, K; Douma, S; Gavriilaki, E; Gkaliagkousi, E; Koletsos, N; Lazaridis, A; Nikolaidou, B; Triantafyllou, A; Vamvakis, A, 2018) |
| "This study was to assess the relationship between asymmetric dimethylarginine (ADMA) and carotid atherosclerosis in patients with essential hypertension." | 3.81 | Asymmetric dimethylarginine is associated with carotid atherosclerosis in patients with essential hypertension. ( Wang, X; Xia, W; Xu, L; Xu, W; Yao, Y, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gkaliagkousi, E | 1 |
| Gavriilaki, E | 1 |
| Triantafyllou, A | 1 |
| Nikolaidou, B | 1 |
| Anyfanti, P | 1 |
| Koletsos, N | 1 |
| Vamvakis, A | 1 |
| Dipla, K | 1 |
| Lazaridis, A | 1 |
| Douma, S | 1 |
| Xia, W | 1 |
| Xu, L | 1 |
| Xu, W | 1 |
| Wang, X | 1 |
| Yao, Y | 1 |
2 other studies available for n(g),n(g')-dimethyl-l-arginine and Essential Hypertension
| Article | Year |
|---|---|
Asymmetric dimethylarginine levels are associated with augmentation index across naïve untreated patients with different hypertension phenotypes.
Topics: Adult; Arginine; Arterial Pressure; Biomarkers; Case-Control Studies; Essential Hypertension; Female | 2018 |
Asymmetric dimethylarginine is associated with carotid atherosclerosis in patients with essential hypertension.
Topics: Arginine; Atherosclerosis; Biomarkers; Blood Pressure; Carotid Artery Diseases; Carotid Artery, Comm | 2015 |